|
1
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sakamoto M: Early HCC: Diagnosis and
molecular markers. J Gastroenterol. 44(Suppl 19): 108–111. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roy K, Wu Y, Meitzler JL, Juhasz A, Liu H,
Jiang G, Lu J, Antony S and Doroshow JH: NADPH oxidases and cancer.
Clin Sci (Lond). 128:863–875. 2015. View Article : Google Scholar
|
|
4
|
De Deken X, Wang D, Many MC, Costagliola
S, Libert F, Vassart G, Dumont JE and Miot F: Cloning of two human
thyroid cDNAs encoding new members of the NADPH oxidase family. J
Biol Chem. 275:23227–23233. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fischer H: Mechanisms and function of DUOX
in epithelia of the lung. Antioxid Redox Signal. 11:2453–2465.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luxen S, Belinsky SA and Knaus UG:
Silencing of DUOX NADPH oxidases by promoter hypermethylation in
lung cancer. Cancer Res. 68:1037–1045. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pulcrano M, Boukheris H, Talbot M, Caillou
B, Dupuy C, Virion A, De Vathaire F and Schlumberger M: Poorly
differentiated follicular thyroid carcinoma: Prognostic factors and
relevance of histological classification. Thyroid. 17:639–646.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ling Q, Shi W, Huang C, Zheng J, Cheng Q,
Yu K, Chen S, Zhang H, Li N and Chen M: Epigenetic silencing of
dual oxidase 1 by promoter hypermethylation in human hepatocellular
carcinoma. Am J Cancer Res. 4:508–517. 2014.PubMed/NCBI
|
|
9
|
Tong L, Chuang CC, Wu S and Zuo L:
Reactive oxygen species in redox cancer therapy. Cancer Lett.
367:18–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sablina AA, Budanov AV, Ilyinskaya GV,
Agapova LS, Kravchenko JE and Chumakov PM: The antioxidant function
of the p53 tumor suppressor. Nat Med. 11:1306–1313. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
D'Autréaux B and Toledano MB: ROS as
signalling molecules: Mechanisms that generate specificity in ROS
homeostasis. Nat Rev Mol Cell Biol. 8:813–824. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bhattacharyya S and Saha J: Tumour,
oxidative stress and host t cell response: Cementing the dominance.
Scand J Immunol. 82:477–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cabello CM, Bair WB III and Wondrak GT:
Experimental therapeutics: Targeting the redox Achilles heel of
cancer. Curr Opin Investig Drugs. 8:1022–1037. 2007.PubMed/NCBI
|
|
14
|
Fruehauf JP and Meyskens FL Jr: Reactive
oxygen species: A breath of life or death? Clin Cancer Res.
13:789–794. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nagasue N, Kohno H, Chang YC, Taniura H,
Yamanoi A, Uchida M, Kimoto T, Takemoto Y, Nakamura T and Yukaya H:
Liver resection for hepatocellular carcinoma. Results of 229
consecutive patients during 11 years. Ann Surg. 217:375–384. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Gokcan H, Savaş N, Oztuna D, Moray G,
Boyvat F and Haberal M: Predictors of survival in hepatocellular
carcinoma patients. Ann Transplant. 20:596–603. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB,
Ha TY, Song GW, Jung DH and Lee SG: The impact of tumor size on
long-term survival outcomes after resection of solitary
hepatocellular carcinoma: Single-institution experience with 2558
patients. J Gastrointest Surg. 19:1281–1290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nickel A, Kohlhaas M and Maack C:
Mitochondrial reactive oxygen species production and elimination. J
Mol Cell Cardiol. 73:26–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ramsey MR and Sharpless NE: ROS as a
tumour suppressor? Nat Cell Biol. 8:1213–1215. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Berndtsson M, Hägg M, Panaretakis T,
Havelka AM, Shoshan MC and Linder S: Acute apoptosis by cisplatin
requires induction of reactive oxygen species but is not associated
with damage to nuclear DNA. Int J Cancer. 120:175–180. 2007.
View Article : Google Scholar
|
|
24
|
Taylor WR and Stark GR: Regulation of the
G2/M transition by p53. Oncogene. 20:1803–1815. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kao WY, Chao Y, Chang CC, Li CP, Su CW,
Huo TI, Huang YH, Chang YJ, Lin HC and Wu JC: Prognosis of
early-stage hepatocellular carcinoma: The clinical implications of
substages of Barcelona Clinic Liver Cancer System based on a cohort
of 1265 patients. Medicine (Baltimore). 94:e19292015. View Article : Google Scholar
|
|
26
|
Hahn WC and Weinberg RA: Rules for making
human tumor cells. N Engl J Med. 347:1593–1603. 2002. View Article : Google Scholar : PubMed/NCBI
|
